279 related articles for article (PubMed ID: 24884974)
1. P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy.
Zhang DG; Zheng JN; Pei DS
Mol Cancer; 2014 May; 13():115. PubMed ID: 24884974
[TBL] [Abstract][Full Text] [Related]
2. [miR-34s--a tumor suppression protein p53 highly related microRNA].
Lou WJ; Chen Q; Liu L; Qian C
Yi Chuan; 2010 May; 32(5):423-30. PubMed ID: 20466628
[TBL] [Abstract][Full Text] [Related]
3. p53 represses c-Myc through induction of the tumor suppressor miR-145.
Sachdeva M; Zhu S; Wu F; Wu H; Walia V; Kumar S; Elble R; Watabe K; Mo YY
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3207-12. PubMed ID: 19202062
[TBL] [Abstract][Full Text] [Related]
4. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
[TBL] [Abstract][Full Text] [Related]
5. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-449 in cell fate determination.
Lizé M; Klimke A; Dobbelstein M
Cell Cycle; 2011 Sep; 10(17):2874-82. PubMed ID: 21857159
[TBL] [Abstract][Full Text] [Related]
7. miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis.
Adlakha YK; Saini N
Cell Death Dis; 2013 Mar; 4(3):e542. PubMed ID: 23492773
[TBL] [Abstract][Full Text] [Related]
8. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
9. The P53/microRNA network: A potential tumor suppressor with a role in anticancer therapy.
Sargolzaei J; Etemadi T; Alyasin A
Pharmacol Res; 2020 Oct; 160():105179. PubMed ID: 32890739
[TBL] [Abstract][Full Text] [Related]
10. Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis.
Nilsson LM; Forshell TZ; Rimpi S; Kreutzer C; Pretsch W; Bornkamm GW; Nilsson JA
PLoS Genet; 2012; 8(3):e1002573. PubMed ID: 22438825
[TBL] [Abstract][Full Text] [Related]
11. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.
Christoffersen NR; Shalgi R; Frankel LB; Leucci E; Lees M; Klausen M; Pilpel Y; Nielsen FC; Oren M; Lund AH
Cell Death Differ; 2010 Feb; 17(2):236-45. PubMed ID: 19696787
[TBL] [Abstract][Full Text] [Related]
12. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.
Braun CJ; Zhang X; Savelyeva I; Wolff S; Moll UM; Schepeler T; Ørntoft TF; Andersen CL; Dobbelstein M
Cancer Res; 2008 Dec; 68(24):10094-104. PubMed ID: 19074875
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
[TBL] [Abstract][Full Text] [Related]
14. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis.
Ramaiah MJ; Pushpavalli SN; Lavanya A; Bhadra K; Haritha V; Patel N; Tamboli JR; Kamal A; Bhadra U; Pal-Bhadra M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5699-706. PubMed ID: 23992861
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
16. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
17. Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53/miR-34a axis.
Zhou B; Yi H; Tan J; Wu Y; Liu G; Qiu Z
Phytother Res; 2015 Mar; 29(3):415-22. PubMed ID: 25572695
[TBL] [Abstract][Full Text] [Related]
18. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling.
Chen J; Li Y; Li Z; Cao L
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22452. PubMed ID: 32052927
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis.
Shirjang S; Mansoori B; Asghari S; Duijf PHG; Mohammadi A; Gjerstorff M; Baradaran B
Free Radic Biol Med; 2019 Aug; 139():1-15. PubMed ID: 31102709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
